<DOC>
	<DOC>NCT00242489</DOC>
	<brief_summary>The purpose of this study is to evaluate the safety and efficacy of etoricoxib in the treatment of osteoarthritis of the knee.</brief_summary>
	<brief_title>Etoricoxib in the Treatment of Osteoarthritis (MK-0663-007)</brief_title>
	<detailed_description />
	<mesh_term>Osteoarthritis</mesh_term>
	<mesh_term>Etoricoxib</mesh_term>
	<mesh_term>Diclofenac</mesh_term>
	<criteria>At least 40 years of age with a clinical diagnosis of Osteoarthritis (OA)of the knee for 6 months prior to study entry (ARA class I, II, or III). Positive therapeutic effect from prior NSAID therapy. Worsening of symptoms upon withdrawal of prior treatment. With the exception of OA, in otherwise good health Weight no more than 280 pounds (male or female). Recent, sustained use of gastroprotective agents. History of arthroscopy of the affected knee within 6 months prior to study entry. History of acute ligamentous or meniscal injury of the study joint within the previous 2 years.</criteria>
	<gender>All</gender>
	<minimum_age>40 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2015</verification_date>
	<keyword>Arcoxia</keyword>
</DOC>